Hoth Therapeutics earnings were -$9.6M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest HOTH earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$3.5M, up 45.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HOTH reported annual earnings of -$8.2M, with 1% growth.
What were Hoth Therapeutics's earnings last quarter?
On HOTH's earnings call on Invalid Date, Hoth Therapeutics (NASDAQ: HOTH) reported Q1 2025 earnings per share (EPS) of -$0.27, up 44.9% year over year. Total HOTH earnings for the quarter were -$3.48 million. In the same quarter last year, Hoth Therapeutics's earnings per share (EPS) was -$0.49.
As of the last Hoth Therapeutics earnings report, Hoth Therapeutics is currently losing money. Hoth Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$9.62 million, a 19.26% increase year over year.
What was HOTH's earnings growth in the past year?
As of Hoth Therapeutics's earnings date in Invalid Date, Hoth Therapeutics's earnings has grown year over year. HOTH earnings in the past year totalled -$9.62 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.